Open original FDA record ↗Recall record
- FDA identifier
- Z-2928-2020
- Company in FDA record
- Stimwave Technologies Inc
- FDA classification date
- Sep 2, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The product contains a non-functional component not referenced in product labeling.
Source facts
- Action
- Field Safety Correction/Advisory Notices were sent to Distributors, Regional Sales Directors, and Territory Managers via email on 07/15/2020, describing the issue, recall instructions and their responsibilities. Prior to this communication, these parties received training on 07/13/2020 on the field action activities identifying the issue, instructions, and their responsibilities as explained in the letter. A physician letter was issued on 08/06/2020 to inform physicians of the recall.
- Initiated
- 2020-07-15
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KY, KS, LA, MD, MO, MI, MN, MA, MS, NC, NM, ND, NV, NY, NE, NJ, OK, OH, OR, PR, PA, RI, SC, TN, TX, UT, VA, WA, WI and the countries of The Netherlands, Belgium, Slovakia, Switzerland, Germany, United Kingdom, Argentina, Italy, Spain, South Africa, Iran, Israel, and Czech Republic.
- Recall number
- Z-2928-2020
- Recall status
- Open, Classified
- CDRH record ID
- 182682
- FDA classified
- 2020-09-02
- Recall event number
- 86115